Beltrán B - Search Results

1

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.

Beltrán B, Iborra M, Sáez-González E, Marqués-Miñana MR, Moret I, Cerrillo E, Tortosa L, Bastida G, Hinojosa J, Poveda-Andrés JL, Nos P. Beltrán B, et al. Dig Dis. 2019;37(2):108-115. doi: 10.1159/000492626. Epub 2018 Aug 27. Dig Dis. 2019. PMID: 30149385

2

[Pharmacological bases of therapy with 5-ASA].

Beltrán B, Martínez-Cuesta MA, Calatayud S, Hinojosa J, Esplugues JV. Beltrán B, et al. Gastroenterol Hepatol. 1997 Jun-Jul;20(6):322-34. Gastroenterol Hepatol. 1997. PMID: 9296850 Review. Spanish. No abstract available.

3

Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease.

Bastida G, Nos P, Aguas M, Beltrán B, Rubín A, Dasí F, Ponce J. Bastida G, et al. Among authors: beltran b. Aliment Pharmacol Ther. 2005 Nov 1;22(9):775-82. doi: 10.1111/j.1365-2036.2005.02636.x. Aliment Pharmacol Ther. 2005. PMID: 16225485 Free article.

4

Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.

Nos P, Bastida G, Beltran B, Aguas M, Ponce J. Nos P, et al. Among authors: beltran b. Am J Gastroenterol. 2006 Sep;101(9):2165-6. doi: 10.1111/j.1572-0241.2006.00763_5.x. Am J Gastroenterol. 2006. PMID: 16968516 No abstract available.

5

Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease.

Beltrán B, Nos P, Bastida G, Iborra M, Hoyos M, Ponce J. Beltrán B, et al. Gut. 2006 Nov;55(11):1670-1. doi: 10.1136/gut.2006.101386. Gut. 2006. PMID: 17047119 Free PMC article. No abstract available.

6

Septic thrombophlebitis of the superior mesenteric vein and multiple liver abscesses in a patient with Crohn's disease at onset.

Aguas M, Bastida G, Nos P, Beltrán B, Grueso JL, Grueso J. Aguas M, et al. Among authors: beltran b. BMC Gastroenterol. 2007 Jun 12;7:22. doi: 10.1186/1471-230X-7-22. BMC Gastroenterol. 2007. PMID: 17565671 Free PMC article.

7

Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?

Pons Beltrán V, Nos P, Bastida G, Beltrán B, Argüello L, Aguas M, Rubín A, Pertejo V, Sala T. Pons Beltrán V, et al. Among authors: beltran b. Gastrointest Endosc. 2007 Sep;66(3):533-40. doi: 10.1016/j.gie.2006.12.059. Gastrointest Endosc. 2007. PMID: 17725942

8

Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy.

Zabana Y, Domènech E, San Román AL, Beltrán B, Cabriada JL, Saro C, Araméndiz R, Ginard D, Hinojosa J, Gisbert JP, Mañosa M, Cabré E, Gassull MA. Zabana Y, et al. Among authors: beltran b. Inflamm Bowel Dis. 2008 Oct;14(10):1387-91. doi: 10.1002/ibd.20496. Inflamm Bowel Dis. 2008. PMID: 18452206

9

Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease.

Beltrán B, Nos P, Dasí F, Iborra M, Bastida G, Martínez M, O'Connor JE, Sáez G, Moret I, Ponce J. Beltrán B, et al. Inflamm Bowel Dis. 2010 Jan;16(1):76-86. doi: 10.1002/ibd.21027. Inflamm Bowel Dis. 2010. PMID: 19637347

10

Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability.

Domènech E, Zabana Y, Garcia-Planella E, López San Román A, Nos P, Ginard D, Gordillo J, Martínez-Silva F, Beltrán B, Mañosa M, Cabré E, Gassull MA. Domènech E, et al. Among authors: beltran b. Aliment Pharmacol Ther. 2010 Jan 15;31(2):233-9. doi: 10.1111/j.1365-2036.2009.04170.x. Epub 2009 Oct 13. Aliment Pharmacol Ther. 2010. PMID: 19832727 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page